| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 02/08/2001 | CA2379993A1 Acyclic and cyclic amine derivatives |
| 02/08/2001 | CA2379538A1 Personal care articles |
| 02/08/2001 | CA2378929A1 Serine proteases |
| 02/08/2001 | CA2374743A1 Human chaperone proteins |
| 02/07/2001 | EP1074558A1 Process for the preparation of mometasone furoate |
| 02/07/2001 | EP1074542A1 Sulfonamide-containing indole compounds |
| 02/07/2001 | EP1074263A2 Pharmaceutical compositions of macrolides or cyclosporine with a polyethoylate saturated hydroxy-fatty acid |
| 02/07/2001 | EP1074260A1 IL-12 Production inhibitor |
| 02/07/2001 | EP1073740A1 Polynucleotides isolated from skin cells and methods for their use |
| 02/07/2001 | EP1073682A1 Heparanase specific molecular probes and their use in research and medical applications |
| 02/07/2001 | EP1073641A2 New substituted amides, their production and their use |
| 02/07/2001 | EP1073639A1 Quinoline derivatives |
| 02/07/2001 | EP1073635A1 Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
| 02/07/2001 | EP1073634A1 Method for producing enantiomer-free n-methyl-n- (1s)-1-phenyl- 2-((3s)- 3-hydroxypyrrolidine- 1-yl)ethyl]- 2,2-diphenyl acetamide |
| 02/07/2001 | EP1073633A2 Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| 02/07/2001 | EP1073632A1 Substituted benzamides, their production and their use as cysteine protease inhibitors |
| 02/07/2001 | EP1073440A1 sPLA 2 INHIBITOR ESTER |
| 02/07/2001 | EP1073430A1 Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders |
| 02/07/2001 | EP1073415A1 Pharmaceutical compositions capable of being gelled |
| 02/07/2001 | EP1073414A1 Use of pharmaceutical compositions capable of being gelled in periodontology |
| 02/07/2001 | CN1283185A New crystalline polymorphic form of 1-methyl-5-p-toluoylpyrroel-2-acetamidoacetic acid guaiacyl ester (MED 15) |
| 02/07/2001 | CN1283183A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity |
| 02/07/2001 | CN1283181A Substituted beta-alanines |
| 02/07/2001 | CN1283106A Pharmaceutical compositions comprising micelles comprising lipophilic glucoiorticosteroid and only one surfactant |
| 02/07/2001 | CN1282744A Preparation of furoic acid momisone |
| 02/07/2001 | CN1282600A Enqlish yew-sufflower tea |
| 02/07/2001 | CN1282596A Baiyinggao for treating internal and external injuries |
| 02/07/2001 | CN1282594A Medical wine (Kepitong) for treating rheumatoid arthritis |
| 02/07/2001 | CN1282592A Plaster for treating bone diseases |
| 02/07/2001 | CN1061548C Wujie medicinal liquor for treating rheumatoid |
| 02/06/2001 | US6184389 Feature a plurality of functional groups attached to backbone and phosphoramidate sites |
| 02/06/2001 | US6184248 Compositions and methods for treatment of neurological disorders and neurodegenerative diseases |
| 02/06/2001 | US6184244 C-terminal modified (N-substituted)-2-indolyl dipeptides as inhibitors of the ICE/ced-3 family of cysteine proteases |
| 02/06/2001 | US6184237 Substituted pyridine compounds and methods of use |
| 02/06/2001 | US6184235 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/06/2001 | US6184226 Antiinflammatory agents for treatment of cardiovascular system disorders/respiratory system disorders, antiischemic agents |
| 02/06/2001 | US6184223 Reverse-turn mimetics and methods relating thereto |
| 02/06/2001 | US6184217 Administering antiinflammatory dosage of a ring-substituted indolocarbazole derivative compound; tumor necrosis factor (tnf) inhibitors |
| 02/06/2001 | US6184207 A peptide including specified piperidine-containing group, having an n-terminal hydrophobic residue and optionally an amidated c-terminal of specified end groups; treating multiple sclerosis or rheumatoid arthritis |
| 02/06/2001 | US6183780 May be used for the application of active substances whenever a certain lag-time before release is advantageous, such as in be the case of anti-asthmatics, anti-emetics, cardiotonics, vasodilators, anti-vertigo and anti-meniere. |
| 02/06/2001 | CA2147807C Bicyclic-aromatic compounds; pharmaceutical and cosmetic compositions containing them and uses |
| 02/06/2001 | CA2106299C Monoclonal and chimeric antibodies specific for human tumor necrosis factor |
| 02/06/2001 | CA2067744C The human c3b/c4b receptor (cr1) |
| 02/06/2001 | CA2024789C Compounds for the treatment of inflammation and allergy |
| 02/03/2001 | CA2314746A1 Use of flupirtin for amelioration of pains in the degenerative joint diseases of dogs and cats |
| 02/01/2001 | WO2001007658A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | WO2001007655A1 Antisense modulation of shp-2 expression |
| 02/01/2001 | WO2001007628A2 Human synthetases |
| 02/01/2001 | WO2001007471A2 Cell cycle and proliferation proteins |
| 02/01/2001 | WO2001007470A2 Human nervous system-associated proteins |
| 02/01/2001 | WO2001007461A1 Antisense modulation of mekk5 expression |
| 02/01/2001 | WO2001007459A1 29 human secreted proteins |
| 02/01/2001 | WO2001007440A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | WO2001007417A1 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 02/01/2001 | WO2001007405A2 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | WO2001007400A1 Carboxylic acid derivatives and adhesion molecule inhibitors containing the same as the active ingredient |
| 02/01/2001 | WO2001007072A1 Modulation of platelet activation |
| 02/01/2001 | WO2001007067A2 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | WO2001007066A2 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | WO2001007057A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | WO2001007053A1 Tixocortol pivalate suspension, mouth-wash based thereon and packaging containing same |
| 02/01/2001 | WO2001007036A1 BICYCLIC ANTAGONISTS SELECTIVE FOR THE αvβ3 INTEGRIN |
| 02/01/2001 | WO2001007024A2 Paracetamol and drotaverine containing composition |
| 02/01/2001 | WO2001006984A2 Small molecules useful in the treatment of inflammatory disease |
| 02/01/2001 | WO2000053742A3 Polynucleotides and proteins encoded thereby |
| 02/01/2001 | WO2000047194A3 METHODS OF TREATING C1s-MEDIATED DISEASES AND CONDITIONS, AND COMPOUNDS AND COMPOSITIONS THEREFOR |
| 02/01/2001 | WO1997045137A8 Methods and compositions useful for inhibition of angiogenesis |
| 02/01/2001 | DE19935771A1 Neue Vitamin D-Derivate mit cyclischen Substrukturen in den Seitenketten, Verfahren und Zwischenprodukte zu ihrer Herstellung und die Verwendung zur Herstellung von Arzneimitteln New vitamin D derivatives with cyclic substructures in the side chains, to processes and intermediates for their preparation and to the use for the preparation of medicaments |
| 02/01/2001 | CA2689694A1 Solutions and methods for inhibition of pain, inflammation and cartilage degradation |
| 02/01/2001 | CA2396591A1 Abc transport polynucleotides, polypeptides, and antibodies |
| 02/01/2001 | CA2383690A1 29 human secreted proteins |
| 02/01/2001 | CA2383017A1 Imidazoimidazoles and triazoles as anti-inflammatory agents |
| 02/01/2001 | CA2382757A1 Carboxylic acid derivatives and adhesion molecule inhibitors which contain the same as effective ingredients |
| 02/01/2001 | CA2380317A1 Human synthetases |
| 02/01/2001 | CA2379784A1 Cell cycle and proliferation proteins |
| 02/01/2001 | CA2378860A1 Bicyclic antagonists selective for the .alpha.v.beta.3 integrin |
| 02/01/2001 | CA2378473A1 Modulation of platelet activation |
| 02/01/2001 | CA2378462A1 Ppar delta inhibitors for the treatment of cardiovascular diseases |
| 02/01/2001 | CA2378395A1 Treatment of angiogenesis dependent conditions with dextrin sulphate |
| 02/01/2001 | CA2376465A1 New vitamin d derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments |
| 02/01/2001 | CA2375571A1 Human nervous system-associated proteins |
| 01/31/2001 | EP1072270A2 Botulinum toxins for treating dystonia |
| 01/31/2001 | EP1072266A1 Thienylazolylalcoxyethanamines, their preparation and their application as medicaments |
| 01/31/2001 | EP1072263A1 Amide derivatives and nociceptin antagonists |
| 01/31/2001 | EP1072261A2 Felbinac-containing patch |
| 01/31/2001 | EP1071781A1 B-cell growth factor related protein |
| 01/31/2001 | EP1071745A2 Process for synthesizing cox-2 inhibitors |
| 01/31/2001 | EP1071708A1 Edg family gene, human h218 |
| 01/31/2001 | EP1071707A1 Novel omega conotoxin peptides |
| 01/31/2001 | EP1071701A1 Non-endogenous, constitutively activated human serotonin receptors and small molecule modulators thereof |
| 01/31/2001 | EP1071686A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071680A1 N,n-disubstituted amides that inhibit the binding of integrins to their receptors |
| 01/31/2001 | EP1071679A1 Novel heterocyclic compounds |
| 01/31/2001 | EP1071666A1 Azacycloalkane derivatives, preparation and therapeutic application |
| 01/31/2001 | EP1071463A1 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 01/31/2001 | EP1071462A1 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 01/31/2001 | EP1071455A1 Terminally-branched polymeric linkers and polymeric conjugates containing the same |
| 01/31/2001 | EP1071449A2 Antagonists of the inflammatory mediator oncostatin m (osm) |
| 01/31/2001 | EP1071440A1 Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 01/31/2001 | EP1071439A1 Rose-hip formulations as anti-inflammatory natural medicine for alleviating/reducing symptoms associated with inflammation and arthritis |